MedTrace Logo

Hearing Aid Signal Processing Comparative Study

NCT04839289 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2023-03-22

Study results available
· View outcomes & findings →

Summary

Participants will be fit with each of two hearing instruments in an ABA cross-over design. The study will consist of a total of three approximately 10-day home trials with the devices. Participants will be asked to provide qualitative feedback to investigators regarding the performance of and their preference for each hearing instrument.

Conditions

  • Hearing Loss, Sensorineural

Interventions

DEVICE

Receiver-in-canal hearing instrument; Manufacturer A

Commercially available receiver-in-canal hearing instrument from manufacturer A

DEVICE

Receiver-in-canal hearing instrument; Manufacturer B

Commercially available receiver-in-canal hearing instrument from manufacturer B

Sponsors & Collaborators

  • Sonova AG

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2021-08-31
Completion
2021-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04839289 on ClinicalTrials.gov